MesoScribe Technologies (United States)

Recent papers from MesoScribe Technologies (United States)

1. Scattering Theory with Asymptotic Completeness for the Boltzmann EquationAnnales Henri Poincaré · 2026
2. Automated identification of phenotypically aberrant cells in acute myeloid leukemia MRD: An unsupervised machine learning approach.Journal of Clinical Oncology · 2026
3. B-218 A comparison of clinical expert to software analysis of T-cell receptor gamma gene rearrangement capillary electrophoresis datasetsClinical Chemistry · 2025
4. A Systematic, Evidence-Based Workflow for Classifying KMT2A Fusions in Acute Myeloid LeukemiaJournal of Molecular Diagnostics · 2025
5. Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaJAMA Oncology · 2024
6. Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing–Based Clonality Testing in B-Cell and Plasma Cell NeoplasmsJournal of Molecular Diagnostics · 2023
7. Improving on-task behavior in children and youth with ADHD: Wearable technology as a possible solution.Journal of Pediatric Neuropsychology · 2023
8. Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencingPLoS ONE · 2021
9. Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality TestingJournal of Molecular Diagnostics · 2020
10. Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myelomaAmerican Journal of Hematology · 2019